Axeleo Capital leads € 16 million Series A for Bioweg

Quakenbrück/ Frank­furt a. M. — Gowling WLG advi­ses Axeleo Capi­tal as lead inves­tor in the €16 million Series A finan­cing round for Bioweg. Bioweg is a German biotech based in Quaken­brück that deve­lops high-perfor­­mance, biode­gra­da­ble ingre­di­ents to replace inten­tio­nally added acrylic poly­­mer-based microplastics. 

The company has closed a €16 million Series A finan­cing round. The round was led by Axeleo Capi­tal Green (from its indus­try fund), toge­ther with EIC Fund, NBank Capi­tal, BonVen­ture and seed inves­tor Dr.-Ing.

The capi­tal will support the cons­truc­tion of Biowe­g’s first bacte­rial cellu­lose plant in Germany and acce­le­rate market entry across Europe. The latest funding round, which brings the total amount raised by the company to date to €32.5 million, will enable the move from pilot to indus­trial produc­tion, inclu­ding the cons­truc­tion of an indus­trial bacte­rial cellu­lose plant in Germany desi­gned to meet the growing demand from indus­trial custo­mers for sustainable, micro­­pla­s­­tic-free ingredients. 

Gowling WLG ‘s German corpo­rate and IP team advi­sed Axeleo Capi­tal on its invest­ment in Bioweg, a German biotech­no­logy company. The team was led by Dr. Michael Lamsa, Part­ner and Co-Head of M&A, Private Equity and Venture Capi­tal in Germany, and supported by Coun­sel Micha Gers­dorf and Asso­ciate Phil­ipp Esmek (both Corporate/M&A; Frank­furt) as well as Part­ner Miray Kavruk and Asso­ciate Ales­san­dra Birken­dorf (both IP/IT; Frankfurt). 

Axeleo Capi­tal is a multi-stra­­tegy tech invest­ment manage­ment firm support­ing Euro­pe’s next leaders in digi­tal and green trans­for­ma­tion, provi­ding seed to Series B invest­ments combi­ned with stra­te­gic, hands-on support to bold backers in key industries.

Dr. Michael Lamsa said: “We are deligh­ted to have legally supported Axeleo Capi­tal as lead inves­tor in this land­mark finan­cing round for Bioweg. Bioweg exem­pli­fies the next gene­ra­tion of sustainable mate­rial inno­va­tion. The invest­ment under­lines not only the confi­dence in the foun­ding team, but also the strong inter­na­tio­nal inte­rest in scalable solu­ti­ons in the field of sustainable mate­ri­als. The market for real alter­na­ti­ves to micro­pla­s­tics is ready and the company is extre­mely well posi­tio­ned to make a real impact with its tech­no­logy, both econo­mic­ally and environmentally.”

Marc Lech­antre, Part­ner at Axeleo Capi­tal, commen­ted: “We are grateful for the strong support of Michael and the team at Gowling WLG, which was criti­cal to this transaction.”

Gowling WLG’s corpo­rate team provi­des excel­lent legal advice through a part­­ner-led service of corpo­rate lawy­ers whose clients range from leading global finan­cial insti­tu­ti­ons and listed compa­nies to private compa­nies and entre­pre­neurs. The 200-strong team has exten­sive expe­ri­ence in all areas of corpo­rate advice, inclu­ding AIM and main market equity capi­tal markets, invest­ment funds, private equity and public and private mergers and acqui­si­ti­ons. —https://gowlingwlg.com/

About Axeleo Capital 

Axeleo Capi­tal is a multi-stra­­tegy tech­no­logy inves­tor back­ing Euro­pe’s next leaders in digi­tal and green trans­for­ma­tion. Alexeo provi­des seed to series B invest­ments combi­ned with stra­te­gic, hands-on support for foun­ders in key indus­tries. With €300 million in assets under manage­ment, 4 successful funds raised and 18 employees, we have made over 70 invest­ments across the EU in recent years and achie­ved 13 successful exits. 

About Gowling WLG

Gowling WLG is an inter­na­tio­nal law firm with more than 1,500 lawy­ers in 20 offices world­wide. We advise clients of all sizes in Germany and abroad across all sectors and prac­ti­ces. We see the world through our clients’ eyes.
Gowling WLG (UK) LLP is a member of Gowling WLG, an inter­na­tio­nal law firm consis­ting of inde­pen­dent and auto­no­mous enti­ties provi­ding services world­wide. — — www.gowlingwlg.com.